KALANasdaqPharmaceutical PreparationsFiscal year ends December 31
KALA BIO, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.19+0.00 (+1.42%)
Close on Oct 19, 2026
- Market cap
- $14.28K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
3.2%
1M of 19M shares
Institutional holders
13
13 new, 0 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
0 buys · 2 sales
Net sold $126.26K
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Baker Bros. Advisors (GP) LLC | 744,759 | 9.99% | 13G (passive) | Oct 2, 2025 |
| Joseph Edelman | 543,745 | 7.70% | 13G (passive) | Sep 4, 2025 |
| David E. Lazar | 49,500,000 | 5.18% | 13D (active) | Jan 30, 2026 |
| Steven A. Cohen | 469,229 | 6.70% | 13G (passive) | Sep 4, 2025 |
| LifeSci Capital LLC | 2,200,000 | 7.90% | 13G (passive) | Dec 30, 2025 |
| Oxford Finance LLC | 1,620,000 | 16.50% | 13G (passive) | Nov 25, 2025 |
| Julian C. Baker | 1,201,894 | 19.70% | 13D (active) amendment | Dec 29, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of KALA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 220,623 | 1.14% | $381.68K | New | 0.00% |
| Geode Capital Management, LLC | 145,152 | 0.75% | $251.11K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 101,396 | 0.52% | $175.42K | New | 0.00% |
| BlackRock, Inc. | 71,542 | 0.37% | $123.77K | New | 0.00% |
| Northern Trust Corp | 41,606 | 0.22% | $71.98K | New | 0.00% |
| Qube Research & Technologies Ltd | 11,073 | 0.06% | $19.16K | New | 0.00% |
| Goldman Sachs Group Inc | 10,921 | 0.06% | $18.89K | New | 0.00% |
| UBS Group AG | 9,057 | 0.05% | $15.67K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 616 | 0.00% | $1.07K | New | 0.00% |
| Barclays PLC | 608 | 0.00% | $1.05K | New | 0.00% |
| Morgan Stanley | 28 | 0.00% | $48 | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 10 | 0.00% | $17 | New | 0.00% |
| International Assets Investment Management, LLC | 2 | 0.00% | $4 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 13 | 1M | 3.2% | 13 / 0 | 0 / 0 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of KALA | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 220,623 | 1.14% | $381.68K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 5,633 | 0.03% | $12.56K | 0.00% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 3,822 | 0.02% | $8.52K | 0.00% | May 31, 2026 |
| Total Stock Market Index Trust | 355 | 0.00% | $614 | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 236 | 0.00% | $526 | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 152 | 0.00% | $339 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Avraham Minkowitz | Chief Executive Officer, Director | – | – | Feb 9, 2026 |
| David E. Lazar | Chief Executive Officer, Director | 0 | – | Dec 22, 2025 |
| Romulus K. Brazzell | SEE REMARKS | 35,952 | 0.19% | Oct 24, 2025 |
| Mary Reumuth | CHIEF FINANCIAL OFFICER | 28,906 | 0.15% | Oct 24, 2025 |
| Darius Kharabi | CHIEF BUSINESS OFFICER | 41,760 | 0.22% | Oct 24, 2025 |
| Brendan P. Purdy | Director | – | – | Feb 9, 2026 |
| Yonatan C. Colman | Director | – | – | Feb 9, 2026 |
| Chaim D. Berger | Director | – | – | Feb 9, 2026 |
| Hillel D. Posen | Director | – | – | Feb 9, 2026 |
| Todd Bazemore | Director | 35,933 | 0.19% | Oct 24, 2025 |
| Mark T. Iwicki | Director | 103,540 | 0.54% | Oct 24, 2025 |
| Andrew I. Koven | Director | 16,972 | 0.09% | Jun 17, 2025 |
| Howard B. Rosen | Director | 16,502 | 0.09% | Jun 17, 2025 |
| Gregory D. Perry | Director | 13,344 | 0.07% | Jun 17, 2025 |
| C. Daniel Myers | Director | 10,374 | 0.05% | Jun 17, 2025 |
| Marjan Farid | Director | 10,242 | 0.05% | Jun 17, 2025 |
| Finance Llc Oxford | 10% owner | 1,620,000 | 8.38% | Dec 3, 2025 |
| Bros. Advisors Lp Baker | – | – | – | Oct 2, 2025 |
| Bros. Advisors (GP) LLC Baker | – | – | – | Oct 2, 2025 |
| Felix Baker | – | 118,496 | 0.61% | Oct 2, 2025 |
| Julian Baker | – | 46,480 | 0.24% | Oct 2, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Mark T. Iwicki Director | Oct 23, 2025 | Sale | −154,894 | $0.81 | $125.46K | 103,540 |
| Mary Reumuth CHIEF FINANCIAL OFFICER | Oct 23, 2025 | Sale | −967 | $0.82 | $793 | 28,906 |
| Romulus K. Brazzell SEE REMARKS | Oct 22, 2025 | Sale | −46,748 | $0.83 | $38.80K | 35,952 |
| Darius Kharabi CHIEF BUSINESS OFFICER | Oct 22, 2025 | Sale | −20,806 | $0.83 | $17.27K | 41,760 |
| Todd Bazemore Director | Oct 22, 2025 | Sale | −47,768 | $0.83 | $39.65K | 35,932 |
| Mary Reumuth CHIEF FINANCIAL OFFICER | Oct 22, 2025 | Sale | −32,230 | $0.83 | $26.75K | 29,873 |
| Julian Baker – | Oct 1, 2025 | Sale | −50,640 | $1.38 | $69.88K | 46,480 |
| Julian Baker – | Oct 1, 2025 | Sale | −462,967 | $1.38 | $638.89K | 425,006 |
| Julian Baker – | Sep 30, 2025 | Sale | −195,425 | $1.60 | $312.68K | 887,973 |
| Julian Baker – | Sep 30, 2025 | Sale | −21,376 | $1.60 | $34.20K | 97,120 |
| Todd Bazemore SEE REMARKS | Jun 24, 2025 | Sale(10b5-1 plan) | −4,058 | $4.01 | $16.27K | 83,699 |
| Darius Kharabi CHIEF BUSINESS OFFICER | Jun 24, 2025 | Sale(10b5-1 plan) | −4,511 | $4.01 | $18.09K | 62,566 |
| Romulus K. Brazzell SEE REMARKS | Jun 24, 2025 | Sale(10b5-1 plan) | −5,251 | $4.01 | $21.06K | 82,698 |
| Mark T. Iwicki Director | Jun 24, 2025 | Sale(10b5-1 plan) | −13,227 | $4.01 | $53.04K | 258,433 |
| Mary Reumuth CHIEF FINANCIAL OFFICER | Jun 24, 2025 | Sale(10b5-1 plan) | −3,631 | $4.01 | $14.56K | 62,100 |
| Gregory D. Perry Director | Jun 15, 2025 | Award | +2,450 | – | – | 13,344 |
| Howard B. Rosen Director | Jun 15, 2025 | Award | +2,450 | – | – | 16,240 |
| Marjan Farid Director | Jun 15, 2025 | Award | +2,450 | – | – | 10,242 |
| C. Daniel Myers Director | Jun 15, 2025 | Award | +2,450 | – | – | 10,374 |
| Andrew I. Koven Director | Jun 15, 2025 | Award | +3,050 | – | – | 16,972 |
| Mark T. Iwicki Director | Jun 15, 2025 | Award | +2,450 | – | – | 271,660 |
| Mark T. Iwicki Director | Jun 3, 2025 | Sale(10b5-1 plan) | −10,866 | $3.74 | $40.64K | 269,210 |
| Darius Kharabi CHIEF BUSINESS OFFICER | Jun 3, 2025 | Sale(10b5-1 plan) | −730 | $3.74 | $2.73K | 67,077 |
| Romulus K. Brazzell SEE REMARKS | Jun 3, 2025 | Sale(10b5-1 plan) | −3,687 | $3.74 | $13.79K | 87,949 |
| Mark T. Iwicki Director | Jun 3, 2025 | Sale(10b5-1 plan) | +10,866 | $3.74 | $40.64K | 269,210 |
| Mary Reumuth CHIEF FINANCIAL OFFICER | Jun 3, 2025 | Sale(10b5-1 plan) | −2,850 | $3.74 | $10.66K | 65,731 |
| Todd Bazemore SEE REMARKS | Jun 3, 2025 | Sale(10b5-1 plan) | −3,390 | $3.74 | $12.68K | 87,757 |
| Romulus K. Brazzell SEE REMARKS | Jan 6, 2025 | Sale(10b5-1 plan) | −2,446 | $7.63 | $18.66K | 92,418 |
| Romulus K. Brazzell SEE REMARKS | Jan 6, 2025 | Award | +10,100 | – | – | 94,864 |
| Mark T. Iwicki CHIEF EXECUTIVE OFFICER, Director | Jan 6, 2025 | Award | +22,100 | – | – | 285,855 |
| Mark T. Iwicki CHIEF EXECUTIVE OFFICER, Director | Jan 6, 2025 | Sale(10b5-1 plan) | −5,779 | $7.63 | $44.09K | 280,076 |
| Todd Bazemore SEE REMARKS | Jan 6, 2025 | Sale(10b5-1 plan) | −1,993 | $7.63 | $15.21K | – |
| Todd Bazemore SEE REMARKS | Jan 6, 2025 | Award | +10,100 | – | – | – |
| Mary Reumuth CHIEF FINANCIAL OFFICER | Jan 6, 2025 | Sale(10b5-1 plan) | −1,706 | $7.63 | $13.02K | 68,581 |
| Mary Reumuth CHIEF FINANCIAL OFFICER | Jan 6, 2025 | Award | +10,100 | – | – | 70,287 |
| Darius Kharabi CHIEF BUSINESS OFFICER | Jan 6, 2025 | Award | +10,100 | – | – | 69,828 |
| Darius Kharabi CHIEF BUSINESS OFFICER | Jan 6, 2025 | Sale(10b5-1 plan) | −2,021 | $7.63 | $15.42K | 67,807 |
| Felix Baker 10% owner | Dec 30, 2024 | Buy | +30,620 | $6.44 | $197.19K | 118,496 |
| Felix Baker 10% owner | Dec 30, 2024 | Buy | +279,939 | $6.44 | $1.80M | 1,083,398 |
| Romulus K. Brazzell SEE REMARKS | Jun 26, 2024 | Sale(10b5-1 plan) | −5,489 | $4.75 | $26.07K | 83,982 |
| Darius Kharabi CHIEF BUSINESS OFFICER | Jun 26, 2024 | Sale(10b5-1 plan) | −5,158 | $4.75 | $24.50K | 59,728 |
| Mary Reumuth CHIEF FINANCIAL OFFICER | Jun 26, 2024 | Sale(10b5-1 plan) | −4,163 | $4.75 | $19.77K | 60,187 |
| Mark T. Iwicki CHIEF EXECUTIVE OFFICER, Director | Jun 26, 2024 | Sale(10b5-1 plan) | −15,168 | $4.75 | $72.05K | 263,755 |
| Todd Bazemore SEE REMARKS | Jun 26, 2024 | Sale(10b5-1 plan) | −4,653 | $4.75 | $22.10K | 83,040 |
| Mark S. Blumenkranz Director | Jun 11, 2024 | Award | +1,400 | – | – | 13,091 |
| Andrew I. Koven Director | Jun 11, 2024 | Award | +1,750 | – | – | 13,922 |
| Howard B. Rosen Director | Jun 11, 2024 | Award | +1,400 | – | – | 13,887 |
| C. Daniel Myers Director | Jun 11, 2024 | Award | +1,400 | – | – | 7,924 |
| Marjan Farid Director | Jun 11, 2024 | Award | +1,400 | – | – | 7,792 |
| Gregory D. Perry Director | Jun 11, 2024 | Award | +1,400 | – | – | 10,894 |
| Darius Kharabi CHIEF BUSINESS OFFICER | May 31, 2024 | Sale(10b5-1 plan) | −231 | $6.09 | $1.41K | 64,886 |
| Romulus K. Brazzell SEE REMARKS | May 31, 2024 | Sale(10b5-1 plan) | −2,002 | $6.09 | $12.19K | 89,471 |
| Todd Bazemore SEE REMARKS | May 31, 2024 | Sale(10b5-1 plan) | −2,093 | $6.09 | $12.75K | 87,693 |
| Mark T. Iwicki CHIEF EXECUTIVE OFFICER, Director | May 31, 2024 | Sale(10b5-1 plan) | −7,392 | $6.09 | $45.02K | 278,923 |
| Mary Reumuth CHIEF FINANCIAL OFFICER | May 31, 2024 | Sale(10b5-1 plan) | −1,786 | $6.09 | $10.88K | 64,350 |
| Romulus K. Brazzell SEE REMARKS | Jan 4, 2024 | Sale(10b5-1 plan) | −1,617 | $6.74 | $10.90K | 91,473 |
| Romulus K. Brazzell SEE REMARKS | Jan 4, 2024 | Award | +6,500 | – | – | 93,090 |
| Mark T. Iwicki CHIEF EXECUTIVE OFFICER, Director | Jan 4, 2024 | Sale(10b5-1 plan) | −4,539 | $6.73 | $30.55K | 286,315 |
| Mark T. Iwicki CHIEF EXECUTIVE OFFICER, Director | Jan 4, 2024 | Award | +14,300 | – | – | 290,854 |
| Mary Reumuth CHIEF FINANCIAL OFFICER | Jan 4, 2024 | Sale(10b5-1 plan) | −1,227 | $6.74 | $8.27K | 66,136 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| I. Koven Andrew Director | Mar 17, 2026 | 14,466 | $3.82K | Mar 17, 2026 | Restricted Stock |
| D. Myers Charles Director | Mar 12, 2026 | 9,112 | $2.86K | Mar 12, 2026 | Restricted Stock |
| B. Rosen Howard Director | Mar 12, 2026 | 13,576 | $3.98K | Mar 12, 2026 | Restricted Stock |
| Iwicki Mark Director | Oct 23, 2025 | 154,894 | $125.19K | Oct 23, 2025 | Restricted Stock |
| Reumuth Mary Officer | Oct 23, 2025 | 967 | $793 | Oct 23, 2025 | Exercised Shares |
| K. Brazzell R Officer | Oct 22, 2025 | 46,748 | $38.96K | Oct 22, 2025 | Performance Shares |
| M. Bazemore Todd Officer | Oct 22, 2025 | 47,768 | $39.69K | Oct 22, 2025 | Restricted Stock |
| Kharabi Darius Officer | Oct 22, 2025 | 20,806 | $17.28K | Oct 22, 2025 | Restricted Stock |
| Reumuth Mary Officer | Oct 22, 2025 | 32,230 | $26.73K | Oct 22, 2025 | Restricted Stock |
| M. Bazemore Todd Officer | Jun 24, 2025 | 4,058 | $16.27K | Jun 24, 2025 | Restricted Stock Unit Vesting |
| Reumuth Mary Officer | Jun 24, 2025 | 3,631 | $14.56K | Jun 24, 2025 | Restricted Stock Unit Vesting |
| T. Iwicki Mark Director | Jun 24, 2025 | 13,227 | $53.04K | Jun 24, 2025 | Restricted Stock Unit Vesting |
| K. Brazzell Romulus Officer | Jun 24, 2025 | 5,251 | $21.06K | Jun 24, 2025 | Restricted Stock Unit Vesting |
| Kharabi Darius Officer | Jun 24, 2025 | 4,511 | $18.09K | Jun 24, 2025 | Restricted Stock Unit Vesting |
| T. Iwicki Mark Director | Jun 3, 2025 | 10,866 | $40.64K | Jun 3, 2025 | Restricted Stock Unit Vesting |